Long-term care & seniors

Boosting immunity in the elderly

In a pre-print, not yet peer reviewed, study led by CITF-funded researchers Drs. Andrew Costa and Dawn Bowdish at McMaster University, people in retirement or nursing homes had repeat blood samples taken to measure immunity after the second and third doses of SARS-COV-2 mRNA vaccines.

2022-04-18T15:01:03-04:00January 10, 2022|Long-term care & seniors|

mRNA vaccines administered with an extended interval between doses elicit strong SARS-CoV-2 antibody responses after two doses

Findings from a real-world vaccination study composed of seniors residing in long-term care facilities were recently released in preprint, therefore not yet peer-reviewed, on behalf of investigators from the CITF-funded study UNCoVER (including Dr. Donald Vinh, Research Institute of the McGill University Health Centre (RI-MUHC) and Dr. Marc-André Langlois, University of Ottawa) and the CITF Secretariat (Dr. Bruce Mazer, Associate Director, Strategy, affiliated with the MUHC).

2022-04-18T15:00:54-04:00October 5, 2021|Long-term care & seniors|
Go to Top